+358.8%
NVDA vs CCL
+37.3%
+321.5%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CCL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.3% | -4.8% | +1.5% | -1.4% |
| 7D | -12.2% | -6.0% | -6.1% | -10.0% |
| 30D | -32.6% | +2.4% | -35.0% | -33.5% |
| 3M | -32.8% | +3.8% | -36.6% | -34.6% |
| 6M | -33.7% | +16.6% | -50.3% | -39.2% |
| YTD | -21.5% | -7.8% | -13.7% | -22.4% |
| 1Y | -21.5% | +8.0% | -29.5% | -28.2% |
| 3Y | +197.0% | +90.4% | +106.6% | +97.7% |
| All | +358.8% | +37.3% | +321.5% | +242.3% |
Cumulative growth
Daily Returns
Daily percentage return beside CCL.
Daily Out/Under-Performance
Portfolio return minus CCL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CCL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CCL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling